Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HLT vs GSK✓SelectedUSD · GSKHLT vs GSK performance historyLatest closeAs of-1.67%11/20
Stock and ETF performance explorer

HLT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+755.1%
GSK return
+75.3%
Excess return
+679.8%
Maximum drawdown
-50.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.7%-0.1%-1.5%-1.6%
7D-4.5%-5.3%+0.8%-3.0%
30D-1.7%-3.7%+2.0%-0.7%
3M+8.1%-7.3%+15.4%+10.3%
6M+10.1%-4.2%+14.3%+11.0%
YTD+24.2%+0.9%+23.3%+23.0%
1Y+35.0%+7.3%+27.8%+31.4%
3Y+112.0%+52.7%+59.2%+79.4%
5Y+150.2%+40.1%+110.1%+115.2%
10Y+639.3%+98.7%+540.6%+448.5%
All+755.1%+75.3%+679.8%+522.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling